We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+14.39%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$344M
AUM Growth
+$39.6M
Cap. Flow
+$2.23M
Cap. Flow %
0.65%
Top 10 Hldgs %
69.57%
Holding
41
New
1
Increased
4
Reduced
6
Closed
–

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$7.5M
2
BG icon
Bunge Global
BG
+$3.07M
3
ADM icon
Archer Daniels Midland
ADM
+$3.05M
4
DAR icon
Darling Ingredients
DAR
+$1.92M
5
FATE icon
Fate Therapeutics
FATE
+$195K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.8M
2
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$2.3M
3
MRK icon
Merck
MRK
+$1.19M
4
DUK icon
Duke Energy
DUK
+$1.11M
5
BHC icon
Bausch Health
BHC
+$659K

Sector Composition

Rank Sector Weight
1 Healthcare 28.09%
2 Utilities 27.27%
3 Industrials 17.64%
4 Financials 8.21%
5 Communication Services 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNL icon
26
Personalis
PSNL
$1.61B
$1.61M 0.47%
300,000
– –
FOCL
27
EDAP TMS S.A.
FOCL
$204M
$1.41M 0.41%
553,652
– –
SIRI icon
28
SiriusXM
SIRI
$10.3B
$1.32M 0.38%
55,784
– –
ASH icon
29
Ashland
ASH
$3.14B
$1.3M 0.38%
15,000
– –
LVTX
30
DELISTED
LAVA Therapeutics
LVTX
$1.28M 0.37%
771,874
– –
FATE icon
31
Fate Therapeutics
FATE
$324M
$1.23M 0.36%
350,000
+50,000
+17% +$195K
MNKD icon
32
MannKind Corp
MNKD
$1.25B
$1.22M 0.36%
195,073
– –
KOD icon
33
Kodiak Sciences
KOD
$2.67B
$1.1M 0.32%
423,000
– –
VTRS icon
34
Viatris
VTRS
$20.1B
$683K 0.2%
58,833
– –
OGN icon
35
Organon & Co
OGN
$3.55B
$600K 0.17%
31,370
– –
CRBU icon
36
Caribou Biosciences
CRBU
$164M
$588K 0.17%
300,000
– –
WEC icon
37
WEC Energy
WEC
$36.9B
$434K 0.13%
4,509
– –
MASS icon
38
908 Devices
MASS
$302M
$237K 0.07%
68,286
– –
WBD icon
39
Warner Bros
WBD
$67.4B
$97.8K 0.03%
11,851
– –
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q3 2024 Portfolio in Review

As of Q3 2024, Bruce & Co held 41 positions worth $344M, up 13% from $304M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 2.4%. Bruce & Co opened 1 new position and made no exits, leaving the 41-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Utilities and Industrials.

  • Bruce & Co's largest Q3 2024 buy was AerCap: 80,000 shares worth $7.58M.
  • Bruce & Co added most to Bunge Global in Q3 2024, an estimated $3.07M increase.
  • Bruce & Co's biggest Q3 2024 reduction was AbbVie, cutting an estimated $2.8M.
  • Bruce & Co's ten largest holdings make up 70% of its $344M portfolio in Q3 2024.
  • Bruce & Co opened 1 new position and closed 0 in Q3 2024.
  • Bruce & Co's portfolio value rose 13% quarter-over-quarter to $344M.

Based on Bruce & Co's 13F filing for Q3 2024, filed 14 Nov 2024.